Subareolar sentinel node biopsy for multiple breast cancers - 26/08/11
Abstract |
Background |
Sentinel lymph node biopsy (SLNB) is deemed suitable only for unifocal breast cancers since multiple foci of cancers may drain to different nodes. We hypothesized that subareolar injection (SI) could identify the sentinel lymph nodes (SLN) accurately in patients with multiple cancers (MC) in the breast.
Methods |
We prospectively employed SI of lymphazurin or technetium sulfur colloid, or both, for the identification of SLN in patients with MC in the breast. All patients underwent axillary dissection to compute the accuracy of SLNB.
Results |
Forty patients presented with MC in the same breast between January 1996 and July 2002. Fifty-two percent (21 of 40) of patients had involvement of more than 1 quadrant; 18% (7 of 40) had more than 1 histologic type of cancers. SLNs were successfully identified in 100% of patients. Axillary disease was present in 63% (25 of 40) of patients. Sensitivity of SLNB was 100% and false negative rate was 0%. The SLN was the only node involved in 45% (18 of 40) of patients.
Conclusions |
SLNB using the SI technique may be an alternative to complete axillary dissection in patients with multiple breast cancers.
Le texte complet de cet article est disponible en PDF.Keywords : Sentinel lymph node biopsy, Multifocal breast cancer, Multicentric breast cancer, Subareolar injection
Plan
Vol 186 - N° 6
P. 730-736 - décembre 2003 Retour au numéro
Article précédent
- Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ
- Cyrus Kotwall, Carla Brinker, Debra Covington, Tana Hall, Mary Sue Hamann, J.Gary Maxwell, Anquonette Stiles, Anna Weiss
- Touch preparation of breast core needle specimens is a new method for same-day diagnosis
- Rena Kass, Ronda S Henry-Tillman, Jacob Nurko, Soheila Korourian, Anne T Mancino, Maureen Colvert, Anita Johnson, Sarah Lane, Rakhshanda Layeeque, Harry Brown, Robert Fincher, Luis De Las Casas, James Waldron, V.Suzanne Klimberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?